Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

97.19
+0.88000.91%
Volume:164.20K
Turnover:15.87M
Market Cap:6.31B
PE:-6.90
High:97.35
Open:96.31
Low:95.49
Close:96.31
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:0.35
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-605.52
PE(LYR):-206.79

Loading ...

May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 03, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Apr 17, 2023

Major Issues Report

8-K - Current report
Apr 14, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 12, 2023

Major Issues Report

8-K - Current report
Apr 06, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2023

Major Issues Report

8-K - Current report
Mar 08, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 19, 2022

Major Issues Report

8-K - Current report
Dec 13, 2022

Major Issues Report

8-K - Current report
Dec 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 29, 2022

Major Issues Report

8-K - Current report